Cannabis and Hemp Industry Investment News

Only company in North America to have developed a product line of hard pills for a variety of cannabinoid and terpenoid blends Holds a Cannabis Standa...

Lexaria Bioscience (NASDAQ: LEXXW- CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactive with news the company is planning for a very busy 202...

Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from Proactive with news the company, which has filed over a...

The new programs come on the heels of a recently-closed oversubscribed financing worth US$11 million Lexaria’s prospective business partners expect ev...

Canntab CEO Larry Latowsky told shareholders that the granting of the patent is another major milestone that confirms the group’s unique offering Cann...

CEO Iris Bincovich: 'The exercise of the warrants indicates that investors are confident in InnoCan Pharma' In other news, following the unexpected ri...

Novel drug delivery platform DehydraTECH masks unwanted tastes, improves onset speed, increases bioavailability of active ingredients Cannabis is the ...

It touted the development as a key "milestone” in the production of CBD-loaded liposomes, as it now permits animal studies and at a later date, human ...

Innocan Pharma (CSE: INNO- OTC: INNPF) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has hit a major milestone in the d...

Reese has over 40 years' experience in public and private businesses and was finance chief at a former Nasdaq-listed energy company "With the new capi...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Corporation () (OTCMKTS:INNPF) (FRA:IP4) reported the su...

The company said its development-stage CBD Loaded Exosome (CLX) Therapy project brings the combination of the cell healing properties of exosomes and ...

Lexaria BioScience (NASDAQ: LEXX- CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactive to bring news the company is now trading on the Nasdaq...

It intends to use the net proceeds of the offering, which includes a $1.44 million up-size option, for R&D studies, patent and legal costs, and ge...

Innocan Pharma (CSE: INNO- OTCPINK: INNPF) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has launched a new consumer we...

The site will allow consumers to browse smoothly through its premium CBD-infused derma cosmetic product collection InnoCan Pharma founder CEO Iris Bin...

"We are pleased to have closed this offering so quickly and with only a few investors,” Canntab CEO Larry Lotowsky said in a statement The debentures ...

"We are pleased to have closed this offering so quickly and with only a few investors,” Canntab CEO Larry Lotowsky said in a statement The debentures ...

InnoCan said it plans to use the offering proceeds for general working capital and other corporate purposes InnoCan Pharma says its investors continue...

Lexaria has commissioned studies to evaluate DehydraTECH’s ability to enhance the delivery and efficacy of four additional antiviral drugs, including ...